Filing Details
- Accession Number:
- 0000950170-24-086051
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-07-24 16:15:03
- Reporting Period:
- 2024-07-22
- Accepted Time:
- 2024-07-24 16:15:03
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1819133 | Tango Therapeutics Inc. | TNGX | () | DE |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1688325 | Trv Gp Iv, Llc | 201 Brookline Ave, Suite 1401 Boston MA 02215 | No | No | No | No | |
| 1688326 | Third Rock Ventures Gp Iv, L.p. | 201 Brookline Ave, Suite 1401 Boston MA 02215 | No | No | No | No | |
| 1688327 | Third Rock Ventures Iv, L.p. | C/O Third Rock Ventures, Llc 201 Brookline Ave, Suite 1401 Boston MA 02215 | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2024-07-22 | 262,740 | $9.78 | 18,197,074 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2024-07-23 | 125,000 | $9.79 | 18,072,074 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.75 to $9.91, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1).
- These shares are directly held by Third Rock Ventures IV, L.P. ("TRV IV"). The general partner of TRV IV is Third Rock Ventures GP IV, L.P. ("TRV GP IV"). The general partner of TRV GP IV is TRV GP IV, LLC ("TRV GP IV LLC"). Each of TRV GP IV and TRV GP IV LLC disclaims beneficial ownership of the shares except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that it is the beneficial owner of such shares.
- The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.75 to $9.90, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (3).
Billionaire Hedge Funds
